In October 2018, IDF held a consultation with its networks, including the Blue Circle Voices (BCV), with the objective of gathering their views on the UN HLM Political Declaration and IDF's preliminary statement. Some 78 participants responded to the survey.

More than 91% of them fully supported the statement.

Cover
Learn more about IDF's networks' views on the matter by downloading the  highlights report.
  • WP prevalence image170 million adults (18-99) are living with diabetes in the IDF Western Pacific Region — 1 in 11 adults. This figure is estimated to increase to 208 million by 2045.
  • The IDF Western Pacific Region is home to 37% of all people living with diabetes worldwide.
  • Over half of people with diabetes (54%) in the IDF Western Pacific Region are undiagnosed.
  • Diabetes was responsible for 1.7 million deaths in the IDF Western Pacific Region in 2017 — the highest number of deaths due to diabetes of all IDF regions.
  • 1 in 8 live births in the IDF Western Pacific Region are affected by hyperglycaemia in pregnancy.
  • USD 136.1 billion was spent on healthcare for people with diabetes in 2017— 16% of the total global health expenditure on diabetes.
WP at a glance


Source: IDF Diabetes Atlas 8th Edition 2017

Diabetes and cardiovascular disease (CVD)

TDH news picPeople with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.

In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.

4219 responses were received from the IDF Western Pacific Region. Download the findings (pdf).

  • SACA prevalence image28 million adults (18-99) are living with diabetes in the IDF SACA Region — 1 in 13 adults. This figure is estimated to increase to 48 million by 2045.
  • 40% of people living with diabetes in the IDF SACA Region are undiagnosed.
  • Diabetes was responsible for 270,000 deaths in the IDF SACA Region in 2017.
  • 10% of people in the IDF SACA Region have Impaired Glucose Tolerance (IGT), which places them at high risk of developing type 2 diabetes.
  • 1 in 8 live births in the IDF SACA Region are affected by hyperglycaemia in pregnancy.
  • USD 33 billion was spent on healthcare for people with diabetes in 2017— 4% of the total global expenditure on diabetes.
SACA at a glance


Source: IDF Diabetes Atlas 8th Edition 2017

Diabetes and cardiovascular disease (CVD)

TDH news picPeople with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.

In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.

936 responses were received from the IDF South and Central America region. Download the findings (pdf).

  • SEA prevalence image84 million adults (18-99) are living with diabetes in the IDF SEA Region — 1 in 12 adults. This figure is estimated to increase to 156 million by 2045.
  • Over half of people with diabetes (58%) in the IDF SEA Region are undiagnosed.
  • Diabetes was responsible for 1.3 million deaths in the IDF SEA Region in 2017. 
  • 1 in 4 live births in the IDF SEA Region are affected by hyperglycaemia in pregnancy.
  • USD 9.7 billion was spent on healthcare for people with diabetes in 2017— the second lowest expenditure of all IDF regions.
SEA at a glance


Source: IDF Diabetes Atlas 8th Edition 2017

Diabetes and cardiovascular disease (CVD)

TDH news picPeople with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.

In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.

929 responses were received from the IDF South-East Asia Region. Download the findings (pdf).

  • NAC prevalence image50 million adults (18-99) are living with diabetes in the IDF North America and Caribbean Region — 1 in 8 adults. This figure is estimated to increase to 73 million by 2045.
  • The prevalence of diabetes in the IDF North America and Caribbean Region is 13% — the highest of all IDF Regions.
  • Over 1 in 3 (38%) of people living with diabetes in the IDF North America and Caribbean Region are undiagnosed.
  • Diabetes was responsible for 378,000 deaths in the IDF Africa Region in 2017. 
  • 58 million adults (18-99) in the IDF North America and Caribbean Region have Impaired Glucose Tolerance (IGT), which places them at high risk of developing type 2 diabetes.
  • 1 in 7 live births in the IDF North America and Caribbean Region are affected by hyperglycaemia in pregnancy.
  • USD 440 billion was spent on healthcare for people with diabetes in 2017— more than in all the other IDF regions combined.
NAC at a glance


Source: IDF Diabetes Atlas 8th Edition 2017

Diabetes and cardiovascular disease (CVD)

TDH news picPeople with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.

In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.

255 responses were received from the IDF North America and Caribbean region. Download the findings (pdf).

© 2019 International Diabetes Federation Disclaimer